Bladder cancer survivors and caregivers will be celebrating the 4th of July with a renewed spirit and new purpose this year. They have banded together to raise awareness of this forgotten cancer, and will officially launch the American Bladder Cancer Society (ABLCS). Reminding Americans that bladder cancer now has a group of dedicated champions throughout the country fighting to save lives, finding a cure, and creating awareness.

Read the rest of this entry »

Children and adolescents living with HIV have higher rates of risk factors for cardiovascular issues than HIV-negative children and adolescents, according to a study published in the June issue of the Journal of Pediatrics, the Miami Herald reports. In addition, many antiretroviral drugs can increase cardiovascular risk factors, the Herald reports.

Read the rest of this entry »

europacolon has called on all governments to implement existing EU recommendations on colorectal cancer screening following a new report published that shows the disease to be significantly neglected despite being the second most common cancer in Europe.1

Read the rest of this entry »

Drugs that suppress HIV are keeping infected individuals alive and relatively healthy for years, even decades. But studies suggest that a new health risk is emerging for these long-term survivors: increased odds for heart attack and stroke.

Read the rest of this entry »

NEW YORK (Reuters Health) - Screening for HIV infection in people older than 55 years of age is likely to be worthwhile in terms of the cost of screening balanced against the potential savings in heath care costs and the gain in years of life, according to a report in the Annals of Internal Medicine.

Read the rest of this entry »

June 23, 2008 (Washington, DC) — The ongoing explosion of information generated by recent revolutions in the “-omics”— genomics, proteomics, metabolomics — requires changes to be made in the way that therapies are developed, approved, and paid for if the potential of personalized medicine is to be realized.

Read the rest of this entry »

NEW YORK (Reuters Health) Jun 23 - Patients coinfected with hepatitis C virus (HCV) and HIV who have high pretreatment LDL cholesterol levels are more likely to respond to HCV therapy than are similar patients with low LDL cholesterol levels, according to a report in the May 11th issue of AIDS.

Read the rest of this entry »

Vermillion, Inc. (Nasdaq: VRML), a molecular diagnostics company, announced that it has submitted a 510(k) pre-market notification application to the U.S. Food & Drug Administration (FDA) requesting regulatory clearance of its Ovarian Tumor Triage Test known as OVA1(TM).

Read the rest of this entry »

The first cross-country report on the management and funding of colorectal cancer (CRC) reveals an urgent need for action to improve the survival of patients diagnosed with this common cancer in Europe and Australia. Key findings from the report published by the London School of Economics (LSE) confirm that few countries have prioritized CRC screening and treatment.

Read the rest of this entry »

June 10, 2008 (Chicago, Illinois) — A provocative new study has shown that erythropoiesis-stimulating agents (ESAs) might have an effect not only on red blood cells but on tumor blood vessels as well. The findings were presented here at the American Society of Clinical Oncology (ASCO) 44th Annual Meeting, where investigators emphasized that the work is preliminary and will require further study.

Read the rest of this entry »